Testing effectiveness (Phase 2)Study completedNCT02028364What this trial is testingPet Imaging as a Biomarker in Hormone Refractory postmenopausaL WomenWho this might be right forBreast Cancer Jules Bordet Institute 55
Testing effectiveness (Phase 2)Looking for participantsNCT05868226What this trial is testingPRE-ISPY Phase I/II Oncology Platform ProgramWho this might be right forHER2-positive Breast CancerMetastatic CancerMetastatic Breast Cancer+29 more QuantumLeap Healthcare Collaborative 280
Large-scale testing (Phase 3)Study completedNCT01547741What this trial is testingDocetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast CancerWho this might be right forBreast Cancer NSABP Foundation Inc 4,242
Post-approval studies (Phase 4)UnknownNCT02089854What this trial is testingAdjuvant Endocrine Therapy for Estrogen Receptor-beta Positive Triple Negative Breast CancerWho this might be right forFemale Breast Cancer Peking Union Medical College Hospital 800
Large-scale testing (Phase 3)Study completedNCT00288002What this trial is testingCombination Chemotherapy With or Without Capecitabine and/or Trastuzumab Before Surgery in Treating Women With Stage I, Stage II, or Stage III Breast CancerWho this might be right forBreast Cancer GBG Forschungs GmbH 1,500
Not applicableStudy completedNCT06363812What this trial is testingProbability of OncotypeDx to Reallocate As Low or High Risk of Recurrence Breast Cancer Patients with Uncertain BiologyWho this might be right forBreast Cancer Fondazione Sandro Pitigliani 258
Testing effectiveness (Phase 2)Study completedNCT02756364What this trial is testingSapanisertib in Combination With Fulvestrant in Women With Advanced or Metastatic Breast Cancer After Aromatase Inhibitor TherapyWho this might be right forBreast Neoplasms Calithera Biosciences, Inc 141
Testing effectiveness (Phase 2)Study completedNCT00856492What this trial is testingS0800, Nab-Paclitaxel, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast CancerWho this might be right forBreast Cancer SWOG Cancer Research Network 215
Early research (Phase 1)Study completedNCT04647487What this trial is testingLY3484356 in Women With Breast Cancer Before Having SurgeryWho this might be right forBreast Cancer Eli Lilly and Company 87
Testing effectiveness (Phase 2)Active Not RecruitingNCT05296746What this trial is testingNeoadjuvant and Adjuvant Ribociclib and ET for Clinically High-risk ER+ and HER2- Breast CancerWho this might be right forBreast Cancer Stage II SOLTI Breast Cancer Research Group 1,100
Large-scale testing (Phase 3)Ended earlyNCT03439046What this trial is testingStudy of the Molecular Features of Postmenopausal Women With HR+ HER2-negative aBC on First-line Treatment With Ribociclib and Letrozole and, in Patients With a PIK3CA Mutation, on Second-line Treatment With Alpelisib Plus FulvestrantWho this might be right forBreast Cancer Novartis Pharmaceuticals 287
Large-scale testing (Phase 3)Study completedNCT01626222What this trial is testing4EVER - Efficacy, Safety, Health Economics, Translational Research of Postmenopausal Women With Estrogen Receptor Positive Locally Advanced or Metastatic Breast CancerWho this might be right forMetastatic Breast Cancer Novartis Pharmaceuticals 301
Testing effectiveness (Phase 2)Looking for participantsNCT06167694What this trial is testingClinical Study of HRS-8080 in Combination With Dalpiciclib Isethionate Tablets in Patients With Unresectable or Metastatic Breast CancerWho this might be right forUnresectable or Metastatic Breast Cancer Shandong Suncadia Medicine Co., Ltd. 146
Testing effectiveness (Phase 2)Looking for participantsNCT06450873What this trial is testingTurkey Tail Mushroom for Treating Post-Menopausal Women With HER2-Negative ER-Positive Breast Cancer Undergoing SurgeryWho this might be right forEstrogen Receptor-Positive Breast CarcinomaHER2-Negative Breast Carcinoma Mayo Clinic 40
Early research (Phase 1)Ended earlyNCT03816839What this trial is testingEvaluation of Orally Administered Amcenestrant (SAR439859) in Japanese Postmenopausal Patients With Advanced Breast Cancer (AMEERA-2)Who this might be right forBreast Cancer Sanofi 10
Testing effectiveness (Phase 2)Looking for participantsNCT07427394What this trial is testingStudy to Evaluate the Safety and Tolerability of Camizestrant in Combination With Atirmociclib in Women With Advanced Breast CancerWho this might be right forAdvanced Breast Cancer AstraZeneca 24
Testing effectiveness (Phase 2)Looking for participantsNCT06953882What this trial is testingImpact of Omitting Chemo Based on Patient's Selection for ER-Positive, HER2-Negative Breast Cancer With Ribociclib and Endocrine TherapyWho this might be right forHER2 Negative Breast Cancer Yale University 140
Large-scale testing (Phase 3)Active Not RecruitingNCT01674140What this trial is testingS1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast CancerWho this might be right forBreast Cancer SWOG Cancer Research Network 1,939
Early research (Phase 1)Study completedNCT01846091What this trial is testingViral Therapy In Treating Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Cancer or Metastatic Breast CancerWho this might be right forEstrogen Receptor NegativeEstrogen Receptor PositiveHead and Neck Squamous Cell Carcinoma+8 more Mayo Clinic 12
Testing effectiveness (Phase 2)Study completedNCT05054374What this trial is testingMirdametinib on Its Own or in Combination With Fulvestrant in People With Solid Tumor CancerWho this might be right forBreast CancerBreast Cancer Stage IVHER2-negative Breast Cancer+4 more Memorial Sloan Kettering Cancer Center 6